Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
letter
. 1970 May 2;2(5704):274–277. doi: 10.1136/bmj.2.5704.274

Thyroid-stimulating Hormone Response to Synthetic Thyrotrophin-releasing Hormone in Man

R Hall, J Amos, R Garry, R L Buxton
PMCID: PMC1700406  PMID: 4986876

Abstract

Synthetic thyrotrophin-releasing hormone, L-pyroglutamyl-L-histidyl-L-proline-amide, has been administered intravenously to euthyroid subjects in doses ranging from 1 to 200 μg. Its effect was assessed by serial measurements of serum thyroid-stimulating hormone (T.S.H.). A rise in serum T.S.H. was detectable five minutes after administration of 50 μg. of thyrotrophin-releasing hormone, reaching a maximum in 15 to 30 minutes, and then gradually declining over the next 120 minutes. Doses of 100 and 200 μg. of thyrotrophin-releasing hormone produced even greater rises of T.S.H. in some cases. The only side-effect noted was transient nausea with doses greater than 50 μg. Measurement of serum T.S.H. levels after administration of thyrotrophin-releasing hormone should prove a useful test of pituitary T.S.H. release and may help to distinguish pituitary and hypothalamic lesions.

Full text

PDF
274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berson S. A., Yalow R. S. Radioimmunoassay of ACTH in plasma. J Clin Invest. 1968 Dec;47(12):2725–2751. doi: 10.1172/JCI105955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bowers C. Y., Lee K. L., Schally A. V. A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide. Endocrinology. 1968 Jan;82(1):75–82. doi: 10.1210/endo-82-1-75. [DOI] [PubMed] [Google Scholar]
  3. Bowers C. Y., Schally A. V., Hawley W. D., Gual C., Parlow A. Effect of thyrotropin-releasing factor in man. J Clin Endocrinol Metab. 1968 Jul;28(7):978–982. doi: 10.1210/jcem-28-7-978. [DOI] [PubMed] [Google Scholar]
  4. Burgus R., Dunn T. F., Ward D. N., Vale W., Amoss M., Guillemin R. Dérivés polypeptidiques de synthèse doués d'activité hypophysiotrope TRF. C R Acad Sci Hebd Seances Acad Sci D. 1969 Apr 21;268(16):2116–2118. [PubMed] [Google Scholar]
  5. Clark F., Brown H. J. Evaluation of Thyopac-3 test in the in-vitro assessment of thyroid function. Br Med J. 1970 Mar 21;1(5698):713–715. doi: 10.1136/bmj.1.5698.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GUILLEMIN R., SAKIZ E., WARD D. N. FURTHER PURIFICATION OF TSH-RELEASING FACTOR (TRF) FROM SHEEP HYPOTHALAMIC TISSUES, WITH OBSERVATIONS ON THE AMINO ACID COMPOSITION. Proc Soc Exp Biol Med. 1965 Apr;118:1132–1137. doi: 10.3181/00379727-118-30063. [DOI] [PubMed] [Google Scholar]
  7. GUILLEMIN R., YAMAZAKI E., GARD D. A., JUTISZ M., SAKIZ E. IN VITRO SECRETION OF THYROTROPIN (TSH): STIMULATION BY A HYPOTHALAMIC PEPTIDE (TRF). Endocrinology. 1963 Nov;73:564–572. doi: 10.1210/endo-73-5-564. [DOI] [PubMed] [Google Scholar]
  8. Gillessen D., Felix A. M., Lergier W., Studer R. O. Synthese des "Thyrotropin-releasing" Hormons (TRH) (Schaf) und verwandter Peptide. Helv Chim Acta. 1970;53(1):63–72. doi: 10.1002/hlca.19700530107. [DOI] [PubMed] [Google Scholar]
  9. Greenwood F. C., Landon J., Stamp T. C. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest. 1966 Apr;45(4):429–436. doi: 10.1172/JCI105357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  11. REICHLIN S., BOSHANS R. L., BROWN J. G. A critical evaluation of the "TRF" of Shibusawa. Endocrinology. 1963 Feb;72:334–336. doi: 10.1210/endo-72-2-334. [DOI] [PubMed] [Google Scholar]
  12. SCHREIBER V., RYBAK M., ECKERTOVA A., KOCI J., JIRGL V., FRANC Z., KMENTOVA V. Isolation of a hypothalamic peptide with TRF (thyreotrophin releasing factor) activity in vitro. Experientia. 1962 Jul 15;18:338–340. doi: 10.1007/BF02151867. [DOI] [PubMed] [Google Scholar]
  13. SHIBUSAWA K., SAITO S., NISHI K., YAMAMOTO T., ABE C., KAWAI T. Effects of the thyrotrophin releasing principle (TRF) after the section of the pituitary stalk. Endocrinol Jpn. 1956 Oct;3(3):151–157. doi: 10.1507/endocrj1954.3.151. [DOI] [PubMed] [Google Scholar]
  14. Schally A. V., Arimura A., Bowers C. Y., Kastin A. J., Sawano S., Reeding T. W. Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res. 1968;24:497–588. doi: 10.1016/b978-1-4831-9827-9.50016-2. [DOI] [PubMed] [Google Scholar]
  15. Schally A. V., Bowers C. Y., Redding T. W., Barrett J. F. Isolation of thyrotropin releasing factor (TRF) from porcine hypothalamus. Biochem Biophys Res Commun. 1966 Oct 20;25(2):165–169. doi: 10.1016/0006-291x(66)90574-2. [DOI] [PubMed] [Google Scholar]
  16. Schally A. V., Bowers C. Y., Redding T. W. Purification of thyrotropic hormone-releasing factor from bovine hypothalamus. Endocrinology. 1966 Apr;78(4):726–732. doi: 10.1210/endo-78-4-726. [DOI] [PubMed] [Google Scholar]
  17. Schally A. V., Redding T. W., Bowers C. Y., Barrett J. F. Isolation and properties of porcine thyrotropin-releasing hormone. J Biol Chem. 1969 Aug 10;244(15):4077–4088. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES